|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910254521403321 |
|
|
Titolo |
Lung Cancer [[electronic resource] ] : Treatment and Research / / edited by Karen L. Reckamp |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2016.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (VI, 322 p. 14 illus., 9 illus. in color.) |
|
|
|
|
|
|
Collana |
|
Cancer Treatment and Research, , 0927-3042 ; ; 170 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Oncology |
Thoracic surgery |
Radiotherapy |
Oncology |
Thoracic Surgery |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters. |
|
|
|
|
|
|
Nota di contenuto |
|
Lung cancer biology -- Screening and prevention -- Diagnosis and molecular classification -- Staging and prognosis -- Treatment—Surgery -- Treatment—Radiation therapy -- Treatment—Chemotherapy.- Treatment—Multimodality therapy -- Targeted therapy -- Resistance to therapy -- Immunotherapy -- Palliative and supportive care.- Geriatric oncology -- Multidisciplinary care -- Small cell lung cancer. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to |
|
|
|
|